Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 767 Jul 12 – Oct 9, 2026
- Disclosed funding
- $66.5B 611 disclosed amounts
- Median round
- $22.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ES Eve SecurityCompany profile Eve Security provides runtime governance for enterprise AI agents: it discovers agents and their connections, then evaluates each action against organizational policies and allows, blocks, modifies or interrogates it before it reaches sensitive systems. Its EveGuard platform is in market with enterprise customers. Eve Security provides runtime governance for enterprise AI agents: it discovers agents and their connections, then evaluates each action against organizational policies and allows, blocks, modifies or interrogates it before it reaches sensitive systems. Its EveGuard platform is in market with enterprise customers. | $4.5M | Seed extensionSeed | Cybersecurity | United States | Investors | |
| F FactoryCompany profile Develops an autonomous software-development platform for enterprise engineering teams. Develops an autonomous software-development platform for enterprise engineering teams. | $200M | FundingUndisclosed | Developer tools | United States | Investors | |
| RF Radian ForgeCompany profile Radian Forge manufactures large, precision metal components for naval, maritime and defense customers using robotic wire-arc additive manufacturing. Its systems deposit metal layer by layer and monitor production for traceability, enabling mission-critical parts to be made faster and closer to shipyards, depots and deployed operations than conventional casting and forging supply chains. Radian Forge manufactures large, precision metal components for naval, maritime and defense customers using robotic wire-arc additive manufacturing. Its systems deposit metal layer by layer and monitor production for traceability, enabling mission-critical parts to be made faster and closer to shipyards, depots and deployed operations than conventional casting and forging supply chains. | $2.5M | Series Seed PreferredSeed | Defense tech | United States | Investors | |
| DD Delos DataCompany profile Delos Data builds an AI inference infrastructure platform spanning cluster software, server systems and data-interface silicon. It connects heterogeneous GPUs, accelerators, memory and storage into a resilient data domain so operators can scale inference workloads with lower latency and avoid interruptions when components or links fail. Delos Data builds an AI inference infrastructure platform spanning cluster software, server systems and data-interface silicon. It connects heterogeneous GPUs, accelerators, memory and storage into a resilient data domain so operators can scale inference workloads with lower latency and avoid interruptions when components or links fail. | >$100M | FundingUndisclosed | AI | United States | Investors | |
| RI RegCell, Inc.Company profile RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development. RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development. | $44M | Series A | Biotech | United States | Investors | |
| RT Retham Technologies, Inc.Company profile Retham is developing HITDx, a functional hospital-lab assay for heparin-induced thrombocytopenia that uses stable cryopreserved donor platelets to make clinically relevant platelet testing more practical; the diagnostic is in validation and regulatory development, while its cryopreserved platelets are available for research use. Retham is developing HITDx, a functional hospital-lab assay for heparin-induced thrombocytopenia that uses stable cryopreserved donor platelets to make clinically relevant platelet testing more practical; the diagnostic is in validation and regulatory development, while its cryopreserved platelets are available for research use. | $1.5M | Seed | Healthtech | United States | Investors | |
| 3D 38 Degrees NorthCompany profile A developer, owner and financing partner for community solar, battery storage and distributed renewable-energy projects. A developer, owner and financing partner for community solar, battery storage and distributed renewable-energy projects. | $260M | Credit facilityUndisclosed | Climate tech | United States | Investors | |
| LC Liquid ComputeCompany profile Liquid Compute is building a market for GPU capacity that connects AI compute buyers, data centers, neoclouds and traders through a physical order book, standardized verification, clearing and settlement; it is onboarding participants while its planned derivatives exchange remains pending CFTC designation and registration. Liquid Compute is building a market for GPU capacity that connects AI compute buyers, data centers, neoclouds and traders through a physical order book, standardized verification, clearing and settlement; it is onboarding participants while its planned derivatives exchange remains pending CFTC designation and registration. | $15M | Seed | AI | United States | Investors | |
| RI ReEmerge, Inc.Company profile ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development. ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development. | $37M | Series A | Healthtech | United States | Investors | |
| PE Polaris Electro-OpticsCompany profile Optical interconnect technology for moving data between AI and data-center systems with lower power consumption. Optical interconnect technology for moving data between AI and data-center systems with lower power consumption. | $50M | Series B | Hardware | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 12, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
55rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
40rounds15led - 3Khosla Ventures
Arena, Vinci, Conway Research
25rounds5led - 4Sequoia Capital
TypeSafe AI, Mecka, Healthleap
23rounds5led - 5Insight Partners
Stuut, Hestus, Inc., Quartermaster
21rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.